These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 16030098

  • 1. Serum concentrations of estrogens, sex hormone binding globulin, and androgens and risk of breast hyperplasia in postmenopausal women.
    Schairer C, Hill D, Sturgeon SR, Fears T, Mies C, Ziegler RG, Hoover RN, Sherman ME.
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1660-5. PubMed ID: 16030098
    [Abstract] [Full Text] [Related]

  • 2. Serum concentrations of estrogens, sex hormone-binding globulin, and androgens and risk of breast cancer in postmenopausal women.
    Adly L, Hill D, Sherman ME, Sturgeon SR, Fears T, Mies C, Ziegler RG, Hoover RN, Schairer C.
    Int J Cancer; 2006 Nov 15; 119(10):2402-7. PubMed ID: 16894564
    [Abstract] [Full Text] [Related]

  • 3. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk.
    Dorgan JF, Longcope C, Stephenson HE, Falk RT, Miller R, Franz C, Kahle L, Campbell WS, Tangrea JA, Schatzkin A.
    Cancer Epidemiol Biomarkers Prev; 1996 Jul 15; 5(7):533-9. PubMed ID: 8827358
    [Abstract] [Full Text] [Related]

  • 4. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE.
    J Natl Cancer Inst; 2004 Dec 15; 96(24):1856-65. PubMed ID: 15601642
    [Abstract] [Full Text] [Related]

  • 5. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, Bingham S, Boeing H, Bueno de Mesquita HB, Chang-Claude J, Clavel-Chapelon F, Fournier A, van Gils CH, Gonzalez CA, Gurrea AB, Critselis E, Khaw KT, Krogh V, Lahmann PH, Nagel G, Olsen A, Onland-Moret NC, Overvad K, Palli D, Panico S, Peeters P, Quirós JR, Roddam A, Thiebaut A, Tjønneland A, Chirlaque MD, Trichopoulou A, Trichopoulos D, Tumino R, Vineis P, Norat T, Ferrari P, Slimani N, Riboli E.
    J Natl Cancer Inst; 2005 May 18; 97(10):755-65. PubMed ID: 15900045
    [Abstract] [Full Text] [Related]

  • 6. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE.
    J Natl Cancer Inst; 2006 Oct 04; 98(19):1406-15. PubMed ID: 17018787
    [Abstract] [Full Text] [Related]

  • 7. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS, Missmer SA, Barbieri RL, Willett WC, Colditz GA, Hankinson SE.
    J Natl Cancer Inst; 2005 Apr 20; 97(8):595-602. PubMed ID: 15840882
    [Abstract] [Full Text] [Related]

  • 8. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition.
    Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PH, Biessy C, Dossus L, Lukanova A, Bingham S, Khaw KT, Allen NE, Bueno-de-Mesquita HB, van Gils CH, Grobbee D, Boeing H, Lahmann PH, Nagel G, Chang-Claude J, Clavel-Chapelon F, Fournier A, Thiébaut A, González CA, Quirós JR, Tormo MJ, Ardanaz E, Amiano P, Krogh V, Palli D, Panico S, Tumino R, Vineis P, Trichopoulou A, Kalapothaki V, Trichopoulos D, Ferrari P, Norat T, Saracci R, Riboli E.
    Endocr Relat Cancer; 2005 Dec 20; 12(4):1071-82. PubMed ID: 16322344
    [Abstract] [Full Text] [Related]

  • 9. Serum sex hormones and breast cancer risk factors in postmenopausal women.
    Lamar CA, Dorgan JF, Longcope C, Stanczyk FZ, Falk RT, Stephenson HE.
    Cancer Epidemiol Biomarkers Prev; 2003 Apr 20; 12(4):380-3. PubMed ID: 12692114
    [Abstract] [Full Text] [Related]

  • 10. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS, Costantino JP, Cummings SR, Wickerham DL, Vogel VG, Dowsett M, Folkerd EJ, Willett WC, Wolmark N, Hankinson SE.
    J Natl Cancer Inst; 2006 Jan 18; 98(2):110-5. PubMed ID: 16418513
    [Abstract] [Full Text] [Related]

  • 11. Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial.
    Chen C, Weiss NS, Stanczyk FZ, Lewis SK, DiTommaso D, Etzioni R, Barnett MJ, Goodman GE.
    Cancer Epidemiol Biomarkers Prev; 2003 Dec 18; 12(12):1410-6. PubMed ID: 14693730
    [Abstract] [Full Text] [Related]

  • 12. Joint effect of insulin-like growth factors and sex steroids on breast cancer risk.
    Yu H, Shu XO, Li BD, Dai Q, Gao YT, Jin F, Zheng W.
    Cancer Epidemiol Biomarkers Prev; 2003 Oct 18; 12(10):1067-73. PubMed ID: 14578144
    [Abstract] [Full Text] [Related]

  • 13. Serum and urinary androgens and risk of breast cancer in postmenopausal women.
    Secreto G, Toniolo P, Berrino F, Recchione C, Cavalleri A, Pisani P, Totis A, Fariselli G, Di Pietro S.
    Cancer Res; 1991 May 15; 51(10):2572-6. PubMed ID: 2021938
    [Abstract] [Full Text] [Related]

  • 14. Circulating steroid hormone levels and risk of breast cancer for postmenopausal women.
    Baglietto L, Severi G, English DR, Krishnan K, Hopper JL, McLean C, Morris HA, Tilley WD, Giles GG.
    Cancer Epidemiol Biomarkers Prev; 2010 Feb 15; 19(2):492-502. PubMed ID: 20086116
    [Abstract] [Full Text] [Related]

  • 15. Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal women.
    Dorgan JF, Stanczyk FZ, Longcope C, Stephenson HE, Chang L, Miller R, Franz C, Falk RT, Kahle L.
    Cancer Epidemiol Biomarkers Prev; 1997 Mar 15; 6(3):177-81. PubMed ID: 9138660
    [Abstract] [Full Text] [Related]

  • 16. Relation of BMI and physical activity to sex hormones in postmenopausal women.
    McTiernan A, Wu L, Chen C, Chlebowski R, Mossavar-Rahmani Y, Modugno F, Perri MG, Stanczyk FZ, Van Horn L, Wang CY, Women's Health Initiative Investigators.
    Obesity (Silver Spring); 2006 Sep 15; 14(9):1662-77. PubMed ID: 17030978
    [Abstract] [Full Text] [Related]

  • 17. Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study.
    Kahán Z, Gardi J, Nyári T, Földesi I, Hajnal-Papp R, Ormándi K, Lázár G, Thurzó L, Schally AV.
    Int J Oncol; 2006 Jul 15; 29(1):193-200. PubMed ID: 16773200
    [Abstract] [Full Text] [Related]

  • 18. Associations between reproductive and menstrual factors and postmenopausal sex hormone concentrations.
    Chubak J, Tworoger SS, Yasui Y, Ulrich CM, Stanczyk FZ, McTiernan A.
    Cancer Epidemiol Biomarkers Prev; 2004 Aug 15; 13(8):1296-301. PubMed ID: 15298949
    [Abstract] [Full Text] [Related]

  • 19. Urinary cadmium and serum levels of estrogens and androgens in postmenopausal Japanese women.
    Nagata C, Nagao Y, Shibuya C, Kashiki Y, Shimizu H.
    Cancer Epidemiol Biomarkers Prev; 2005 Mar 15; 14(3):705-8. PubMed ID: 15767353
    [Abstract] [Full Text] [Related]

  • 20. Urinary phytoestrogen excretion and breast cancer risk: evaluating potential effect modifiers endogenous estrogens and anthropometrics.
    Dai Q, Franke AA, Yu H, Shu XO, Jin F, Hebert JR, Custer LJ, Gao YT, Zheng W.
    Cancer Epidemiol Biomarkers Prev; 2003 Jun 15; 12(6):497-502. PubMed ID: 12814993
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.